|
1
|
Seystahl K and Weller M: Is there a world
beyond bevacizumab in targeting angiogenesis in glioblastoma?
Expert Opin Investig Drugs. 21:605–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hillen F and Griffioen AW: Tumour
vascularization: Sprouting angiogenesis and beyond. Cancer
Metastasis Rev. 26:489–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe’er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paulis YW, Soetekouw PM, Verheul HM,
Tjan-Heijnen VC and Griffioen AW: Signalling pathways in
vasculogenic mimicry. Biochim Biophys Acta. 1806:18–28.
2010.PubMed/NCBI
|
|
5
|
van der Schaft DW, Hillen F, Pauwels P,
Kirschmann DA, Castermans K, Egbrink MG, Tran MG, Sciot R, Hauben
E, Hogendoorn PC, et al: Tumor cell plasticity in Ewing sarcoma, an
alternative circulatory system stimulated by hypoxia. Cancer Res.
65:11520–11528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Schaft DW, Seftor RE, Seftor EA,
Hess AR, Gruman LM, Kirschmann DA, Yokoyama Y, Griffioen AW and
Hendrix MJ: Effects of angiogenesis inhibitors on vascular network
formation by human endothelial and melanoma cells. J Natl Cancer
Inst. 96:1473–1477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pàez-Ribes M, Allen E, Hudock J, Takeda T,
Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D and Casanovas O:
Antiangiogenic therapy elicits malignant progression of tumors to
increased local invasion and distant metastasis. Cancer Cell.
15:220–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folberg R and Maniotis AJ: Vasculogenic
mimicry. APMIS. 112:508–525. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YS and Chen ZP: Vasculogenic mimicry:
A novel target for glioma therapy. Chin J Cancer. 33:74–79. 2014.
View Article : Google Scholar :
|
|
10
|
Yang Z, Sun B, Zhao X, Shao B, An J, Gu Q,
Wang Y, Dong X, Zhang Y and Qiu Z: Erythropoietin and
erythropoietin receptor in hepatocellular carcinoma: Correlation
with vasculogenic mimicry and poor prognosis. Int J Clin Exp
Pathol. 8:4033–4043. 2015.PubMed/NCBI
|
|
11
|
Liu T, Sun B, Zhao X, Li Y, Gu Q, Dong X
and Liu F: OCT4 expression and vasculogenic mimicry formation
positively correlate with poor prognosis in human breast cancer.
Int J Mol Sci. 15:19634–19649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang SY, Ke YQ, Lu GH, Song ZH, Yu L, Xiao
S, Sun XL, Jiang XD, Yang ZL and Hu CC: Vasculogenic mimicry is a
prognostic factor for postoperative survival in patients with
glioblastoma. J Neurooncol. 112:339–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ping YF and Bian XW: Consice review:
Contribution of cancer stem cells to neovascularization. Stem
Cells. 29:888–894. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Lin P, Sun B, Zhang S, Cai W, Han
C, Li L, Lu H and Zhao X: Epithelial-mesenchymal transition
regulated by EphA2 contributes to vasculogenic mimicry formation of
head and neck squamous cell carcinoma. Biomed Res Int.
2014:8039142014.PubMed/NCBI
|
|
16
|
Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q,
An J, Dong X, Liu F and Wang Y: ZEB2 promotes vasculogenic mimicry
by TGF-β1 induced epithelial-to-mesenchymal transition in
hepatocellular carcinoma. Exp Mol Pathol. 98:352–359. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang H, Lee M and Jang SW: Celastrol
inhibits TGF-β1-induced epithelial-mesenchymal transition by
inhibiting Snail and regulating E-cadherin expression. Biochem
Biophys Res Commun. 437:550–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
May CD, Sphyris N, Evans KW, Werden SJ,
Guo W and Mani SA: Epithelial-mesenchymal transition and cancer
stem cells: A dangerously dynamic duo in breast cancer progression.
Breast Cancer Res. 13:2022011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lindsey S and Langhans SA: Cross talk of
oncogenic signaling pathways during epithelial-mesenchymal
transition. Front Oncol. 4:3582014. View Article : Google Scholar
|
|
22
|
Kang Y, Siegel PM, Shu W, Drobnjak M,
Kakonen SM, Cordón-Cardo C, Guise TA and Massagué J: A multigenic
program mediating breast cancer metastasis to bone. Cancer Cell.
3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sánchez-Elsner T, Botella LM, Velasco B,
Corbí A, Attisano L and Bernabéu C: Synergistic cooperation between
hypoxia and transforming growth factor-beta pathways on human
vascular endothelial growth factor gene expression. J Biol Chem.
276:38527–38535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ling G, Wang S, Song Z, Sun X, Liu Y,
Jiang X, Cai Y, Du M and Ke Y: Transforming growth factor-β is
required for vasculogenic mimicry formation in glioma cell line
U251MG. Cancer Biol Ther. 12:978–988. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seftor RE, Seftor EA, Koshikawa N, Meltzer
PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V and
Hendrix MJ: Cooperative interactions of laminin 5 gamma2 chain,
matrix metalloproteinase-2, and membrane
type-1-matrix/metalloproteinase are required for mimicry of
embryonic vasculogenesis by aggressive melanoma. Cancer Res.
61:6322–6327. 2001.PubMed/NCBI
|
|
26
|
Yue WY and Chen ZP: Does vasculogenic
mimicry exist in astrocytoma? J Histochem Cytochem. 53:997–1002.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jain RK: Normalization of tumor
vasculature: An emerging concept in antiangiogenic therapy.
Science. 307:58–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Bock K, Cauwenberghs S and Carmeliet P:
Vessel abnormalization: Another hallmark of cancer? Molecular
mechanisms and therapeutic implications. Curr Opin Genet Dev.
21:73–79. 2011. View Article : Google Scholar
|
|
30
|
Dieterich LC, Mellberg S, Langenkamp E,
Zhang L, Zieba A, Salomäki H, Teichert M, Huang H, Edqvist PH,
Kraus T, et al: Transcriptional profiling of human glioblastoma
vessels indicates a key role of VEGF-A and TGFβ2 in vascular
abnormalization. J Pathol. 228:378–390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song J: EMT or apoptosis: A decision for
TGF-beta. Cell Res. 17:289–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morrison CD, Parvani JG and Schiemann WP:
The relevance of the TGF-β paradox to EMT-MET programs. Cancer
Lett. 341:30–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Willis BC and Borok Z: TGF-β-induced EMT:
Mechanisms and implications for fibrotic lung disease. Am J Physiol
Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wendt MK, Tian M and Schiemann WP:
Deconstructing the mechanisms and consequences of TGF-β-induced EMT
during cancer progression. Cell Tissue Res. 347:85–101. 2012.
View Article : Google Scholar
|
|
36
|
Zhao HW, Li YW, Feng R, Yu JB, Li J, Zhang
Y, Li JC and Wang YX: TGF-β/Smad2/3 signal pathway involves in U251
cell proliferation and apoptosis. Gene. 562:76–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Z, Bandyopadhyay A, Nichols RW, Wang
L, Hinck AP, Wang S and Sun LZ: Blockade of autocrine TGF-β
signaling inhibits stem cell phenotype, survival, and metastasis of
murine breast cancer cells. J Stem Cell Res Ther. 2:1–8. 2012.
View Article : Google Scholar
|
|
38
|
Liu J, Liao S, Diop-Frimpong B, Chen W,
Goel S, Naxerova K, Ancukiewicz M, Boucher Y, Jain RK and Xu L:
TGF-β blockade improves the distribution and efficacy of
therapeutics in breast carcinoma by normalizing the tumor stroma.
Proc Natl Acad Sci USA. 109:16618–16623. 2012. View Article : Google Scholar
|
|
39
|
Lu XS, Sun W, Ge CY, Zhang WZ and Fan YZ:
Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin
signaling pathways to tumor growth and vasculogenic mimicry of
gall-bladder carcinomas. Int J Oncol. 42:2103–2115. 2013.PubMed/NCBI
|
|
40
|
Chen HH, Zhou XL, Shi YL and Yang J: Roles
of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to
mesenchymal transition. Arch Med Res. 44:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Milone MR, Pucci B, Bruzzese F, Carbone C,
Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M,
et al: Acquired resistance to zoledronic acid and the parallel
acquisition of an aggressive phenotype are mediated by p38-MAP
kinase activation in prostate cancer cells. Cell Death Dis.
4:e6412013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yi Y, Kim HJ, Mi P, Zheng M, Takemoto H,
Toh K, Kim BS, Hayashi K, Naito M, Matsumoto Y, et al: Targeted
systemic delivery of siRNA to cervical cancer model using cyclic
RGD-installed unimer polyion complex-assembled gold nanoparticles.
J Control Release. Aug 30–2016.pii: S0168-3659(16)30626-5.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Basha G, Ordobadi M, Scott WR, Cottle A,
Liu Y, Wang H and Cullis PR: Lipid nanoparticle delivery of siRNA
to osteocytes leads to effective silencing of SOST and inhibition
of sclerostin in vivo. Mol Ther Nucleic Acids. 5:e3632016.
View Article : Google Scholar : PubMed/NCBI
|
